AMENDED AND RESTATED EMPLOYMENT AGREEMENT
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Employment Agreement”), effective as of July 1, 2023 (“Agreement Effective Date”), is made by and between Aclaris Therapeutics, Inc., a corporation organized under the laws of the State of Delaware (“Employer”) and Joseph Monahan (“Executive”).
WHEREAS, Executive is employed by and performing services for Employer pursuant to an Employment Agreement with Employer effective as of January 12, 2022 (the “Prior Agreement”);
WHEREAS, Executive desires to continue to provide services to Employer and Employer desires to continue to employ Executive and, in connection therewith, to compensate Executive for his services to Employer;
WHEREAS, this Amended and Restated Employment Agreement amends, restates, replaces and supersedes in its entirety Executive’s Prior Agreement;
WHEREAS, Executive and Employer agree that this Employment Agreement sets forth the terms and conditions of Executive’s employment with Employer as of the Agreement Effective Date; and
WHEREAS, this Employment Agreement has been duly approved and its execution has been duly authorized by the Compensation Committee of Employer’s Board of Directors.
NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein Employer and Executive hereby agree as follows:
SECTION 1. EMPLOYMENT
1.1General. Employer hereby agrees to continue to employ Executive in the capacity of Chief Scientific Officer (“CSO”). Executive hereby accepts such continued employment upon the terms and subject to the conditions herein contained.
1.2Authority and Duties. Executive shall continue to have full responsibility as the CSO of Employer and all authority normally accorded to such position. Executive agrees to perform such duties and responsibilities commensurate with the position of CSO as may reasonably be determined by the Board of Directors of Employer (the “Board”).
1.2.1 Reporting. During Executive’s employment with Employer, Executive will continue to report directly to, and take direction from, the Chief Executive Officer (the “CEO”).
1.2.2 Time to Be Devoted to Employment. As of the Agreement Effective Date, Executive will shift to part-time status and will be expected to perform services at 60% of a full-time schedule (or approximately 24 hours per week). Executive shall continue to diligently devote his efforts, business time, attention and energies to the business of Employer and will not, while employed by Employer, undertake or engage in any other employment, occupation or business enterprise that would interfere with Executive’s responsibilities and the performance of